8-K/A

AMENDMENT TO FORM 8-K

Company: Protara Therapeutics, Inc.
Filed: March 20, 2020
Period of Report: January 6, 2020
Accession Number: 0001213900-20-006918

View Document ↗ View on SEC.gov ↗